| Frdaniel Britt Boyd, MD | |
|
88 Martin Luther King Jr Dr, Forsyth, GA 31029-1682 | |
| (478) 994-2521 | |
| Not Available |
| Full Name | Frdaniel Britt Boyd |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 19 Years |
| Location | 88 Martin Luther King Jr Dr, Forsyth, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285811687 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 64780 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Georgia Clinic, Pc | 8426949587 | 24 |
News Archive
Metrohm USA and Metrohm Canada are pleased to announce the winner of the 2015 Young Chemist Award, Chad Atkins. Chad is completing his Ph.D. at the University of British Columbia where he works under the supervision of Robin Turner and Michael Blades.
Pearl Therapeutics Inc. today announced positive top-line results from a randomized, double-blind, Phase 2b, dose-ranging study of glycopyrrolate, a long-acting muscarinic agonist (LAMA) delivered twice a day (BID) via metered-dose inhaler in patients with moderate-to-severe COPD.
The Food and Drug Administration declared Wednesday that vaping among teenagers has reached "an epidemic proportion." The agency told five major e-cigarette manufacturers that they had 60 days to find ways to keep their products away from minors.
Today's health policy headlines examine the solvency of Medicare and Social Security; the momentum of legislation in Congress to provide states with Medicaid assistance; and the impact of Missouri's ballot challenge to health reform.
› Verified 9 days ago
| Entity Name | Georgia Clinic, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609816123 PECOS PAC ID: 8426949587 Enrollment ID: O20040320000451 |
News Archive
Metrohm USA and Metrohm Canada are pleased to announce the winner of the 2015 Young Chemist Award, Chad Atkins. Chad is completing his Ph.D. at the University of British Columbia where he works under the supervision of Robin Turner and Michael Blades.
Pearl Therapeutics Inc. today announced positive top-line results from a randomized, double-blind, Phase 2b, dose-ranging study of glycopyrrolate, a long-acting muscarinic agonist (LAMA) delivered twice a day (BID) via metered-dose inhaler in patients with moderate-to-severe COPD.
The Food and Drug Administration declared Wednesday that vaping among teenagers has reached "an epidemic proportion." The agency told five major e-cigarette manufacturers that they had 60 days to find ways to keep their products away from minors.
Today's health policy headlines examine the solvency of Medicare and Social Security; the momentum of legislation in Congress to provide states with Medicaid assistance; and the impact of Missouri's ballot challenge to health reform.
› Verified 9 days ago
| Entity Name | Atlantamed Uc Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699450098 PECOS PAC ID: 8022471358 Enrollment ID: O20230901003341 |
News Archive
Metrohm USA and Metrohm Canada are pleased to announce the winner of the 2015 Young Chemist Award, Chad Atkins. Chad is completing his Ph.D. at the University of British Columbia where he works under the supervision of Robin Turner and Michael Blades.
Pearl Therapeutics Inc. today announced positive top-line results from a randomized, double-blind, Phase 2b, dose-ranging study of glycopyrrolate, a long-acting muscarinic agonist (LAMA) delivered twice a day (BID) via metered-dose inhaler in patients with moderate-to-severe COPD.
The Food and Drug Administration declared Wednesday that vaping among teenagers has reached "an epidemic proportion." The agency told five major e-cigarette manufacturers that they had 60 days to find ways to keep their products away from minors.
Today's health policy headlines examine the solvency of Medicare and Social Security; the momentum of legislation in Congress to provide states with Medicaid assistance; and the impact of Missouri's ballot challenge to health reform.
› Verified 9 days ago
| Entity Name | Atlantamed Fp, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457036840 PECOS PAC ID: 7416311147 Enrollment ID: O20230914001055 |
News Archive
Metrohm USA and Metrohm Canada are pleased to announce the winner of the 2015 Young Chemist Award, Chad Atkins. Chad is completing his Ph.D. at the University of British Columbia where he works under the supervision of Robin Turner and Michael Blades.
Pearl Therapeutics Inc. today announced positive top-line results from a randomized, double-blind, Phase 2b, dose-ranging study of glycopyrrolate, a long-acting muscarinic agonist (LAMA) delivered twice a day (BID) via metered-dose inhaler in patients with moderate-to-severe COPD.
The Food and Drug Administration declared Wednesday that vaping among teenagers has reached "an epidemic proportion." The agency told five major e-cigarette manufacturers that they had 60 days to find ways to keep their products away from minors.
Today's health policy headlines examine the solvency of Medicare and Social Security; the momentum of legislation in Congress to provide states with Medicaid assistance; and the impact of Missouri's ballot challenge to health reform.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Frdaniel Britt Boyd, MD 415 Gatehouse Ct, Alpharetta, GA 30009-3490 Ph: (404) 556-3886 | Frdaniel Britt Boyd, MD 88 Martin Luther King Jr Dr, Forsyth, GA 31029-1682 Ph: (478) 994-2521 |
News Archive
Metrohm USA and Metrohm Canada are pleased to announce the winner of the 2015 Young Chemist Award, Chad Atkins. Chad is completing his Ph.D. at the University of British Columbia where he works under the supervision of Robin Turner and Michael Blades.
Pearl Therapeutics Inc. today announced positive top-line results from a randomized, double-blind, Phase 2b, dose-ranging study of glycopyrrolate, a long-acting muscarinic agonist (LAMA) delivered twice a day (BID) via metered-dose inhaler in patients with moderate-to-severe COPD.
The Food and Drug Administration declared Wednesday that vaping among teenagers has reached "an epidemic proportion." The agency told five major e-cigarette manufacturers that they had 60 days to find ways to keep their products away from minors.
Today's health policy headlines examine the solvency of Medicare and Social Security; the momentum of legislation in Congress to provide states with Medicaid assistance; and the impact of Missouri's ballot challenge to health reform.
› Verified 9 days ago
Laurie Elizabeth Cochran, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 N Lee St Ste A, Forsyth, GA 31029 Phone: 478-994-0437 Fax: 478-994-6787 | |
William Stephen Taunton Sr., MD Family Medicine Medicare: Medicare Enrolled Practice Location: 120 N Lee St, Suite A, Forsyth, GA 31029 Phone: 478-994-0437 Fax: 478-994-6787 | |
Dr. Joel Robert Fountain Jr., M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 411 Taylor Dr, Forsyth, GA 31029 Phone: 478-954-2188 | |
Patton P Smith, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 90-a Martin Luther King Jr Drive, Forsyth, GA 31029 Phone: 478-994-0437 Fax: 478-994-6787 | |
Ainny Shamim, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 88 Martin Luther King Jr Dr, Forsyth, GA 31029 Phone: 478-994-2521 |